Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Product containing darunavir (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Darunavir (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely darunavir 300 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Darunavir (substance) |
Inferred relationship |
Some |
|
Darunavir ethanolate (substance) |
Is a |
False |
Darunavir (substance) |
Inferred relationship |
Some |
|
Daruavir ethanolate |
Is a |
False |
Darunavir (substance) |
Inferred relationship |
Some |
|
Product containing precisely darunavir 400 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Darunavir (substance) |
Inferred relationship |
Some |
|
Darunavir 600 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Darunavir (substance) |
Inferred relationship |
Some |
|
Allergy to darunavir |
Causative agent (attribute) |
True |
Darunavir (substance) |
Inferred relationship |
Some |
1 |
Darunavir-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Darunavir (substance) |
Inferred relationship |
Some |
1 |
Product containing cobicistat and darunavir (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Darunavir (substance) |
Inferred relationship |
Some |
1 |
Product containing cobicistat and darunavir in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Darunavir (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely darunavir 300 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Darunavir (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely darunavir 300 milligram/1 each conventional release oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Darunavir (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely darunavir 400 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Darunavir (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely darunavir 400 milligram/1 each conventional release oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Darunavir (substance) |
Inferred relationship |
Some |
1 |
Darunavir 600 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Darunavir (substance) |
Inferred relationship |
Some |
1 |
Darunavir 600 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Darunavir (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely darunavir 300 milligram/1 each conventional release oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Darunavir (substance) |
Inferred relationship |
Some |
1 |
Darunavir 600 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Darunavir (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely darunavir 400 milligram/1 each conventional release oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Darunavir (substance) |
Inferred relationship |
Some |
1 |
Darunavir ethanolate (substance) |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Darunavir (substance) |
Inferred relationship |
Some |
|
Product containing only darunavir (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Darunavir (substance) |
Inferred relationship |
Some |
1 |
Cobicistat and darunavir only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Darunavir (substance) |
Inferred relationship |
Some |
1 |
Cobicistat and darunavir only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Darunavir (substance) |
Inferred relationship |
Some |
1 |
Product containing only darunavir in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Darunavir (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely darunavir (as darunavir ethanolate) 400 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Darunavir (substance) |
Inferred relationship |
Some |
1 |
Darunavir (as darunavir ethanolate) 600 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Darunavir (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely darunavir (as darunavir ethanolate) 300 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Darunavir (substance) |
Inferred relationship |
Some |
1 |
Darunavir (as darunavir ethanolate) 800 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Darunavir (substance) |
Inferred relationship |
Some |
1 |
Darunavir 800 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Darunavir (substance) |
Inferred relationship |
Some |
1 |
Darunavir 800 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Darunavir (substance) |
Inferred relationship |
Some |
1 |
Darunavir propylene glycolate |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Darunavir (substance) |
Inferred relationship |
Some |
|
Darunavir (as darunavir propylene glycolate) 800 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Darunavir (substance) |
Inferred relationship |
Some |
1 |
Darunavir (as darunavir ethanolate) 100 mg/mL oral suspension |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Darunavir (substance) |
Inferred relationship |
Some |
1 |
Darunavir 600 mg and ritonavir 100 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Darunavir (substance) |
Inferred relationship |
Some |
2 |
Darunavir 600 mg and ritonavir 100 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Darunavir (substance) |
Inferred relationship |
Some |
2 |
Darunavir and ritonavir only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Darunavir (substance) |
Inferred relationship |
Some |
2 |
Product containing darunavir and ritonavir (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Darunavir (substance) |
Inferred relationship |
Some |
2 |
Product containing darunavir and ritonavir in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Darunavir (substance) |
Inferred relationship |
Some |
2 |
Darunavir and ritonavir only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Darunavir (substance) |
Inferred relationship |
Some |
2 |
Product containing precisely darunavir (as darunavir ethanolate) 75 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Darunavir (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely cobicistat 150 milligram and darunavir (as darunavir ethanolate) 800 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Darunavir (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely darunavir (as darunavir propylene glycolate) 600 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Darunavir (substance) |
Inferred relationship |
Some |
1 |